KarimRichardMasriMDRhMSUS

PubMed

• 1 citations
  Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a ph...
  Maya H Buch, Deepak L Bhatt, Jon T Giles, Gary G Koch, Edward Nagy, Hyejin Jo, Kenneth Kwok, Carol A Connell, Arne Yndestad, Christina Charles-Schoeman, Ted Mikuls, St...> ;RMD Open. 2024 Apr 12
• Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting.
  Jacqueline O'Brien, Page C Moore, Miao Yu, Peter Hur, Joshua F Baker, Catherine Bakewell, Ara Dikranian, Gordon Lam, Karim R Masri> ;Rheumatology and Therapy. 2024 Mar 20
• Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results from the CorEvitas Rheumatoid Arthritis Registry.
  Dimitrios A Pappas, Jacqueline O'Brien, Page C Moore, Rhiannon Dodge, Rebecca Germino, Karim R Masri, Clifton O Bingham 3rd, Laura C Cappelli> ;The Journal of Rheumatology. 2024 Feb 15
• 6 citations
  Effect of Leflunomide on Pegloticase Response Rate in Patients with Uncontrolled Gout: A Retrospective Study.
  Karim Richard Masri, Lissa Padnick-Silver, Kevin Winterling, Brian LaMoreaux> ;Rheumatology and Therapy. 2022 Apr 1
• 3 citations
  Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response.
  John K Botson, Herbert S B Baraf, Robert T Keenan, John Albert, Karim R Masri, Jeff Peterson, Christianne Yung, Brigid Freyne, Mona Amin, Abdul Abdellatif, Nehad Solom...> ;Current Rheumatology Reports. 2022 Jan 1
• 23 citations
  The effect of immunomodulators on the efficacy and tolerability of pegloticase: a systematic review.
  Robert T. Keenan, John K. Botson, Karim R. Masri, Lissa Padnick-Silver, Brian LaMoreaux, John A. Albert, Michael H. Pillinger> ;Seminars in Arthritis and Rheumatism. 2021 Apr 1
• 3 citations
  IgG4-related systemic disease: an uncommon presentation for an uncommon disease.
  Karim R Masri, Timothy S. Shaver> ;Rheumatology International. 2013 Feb 1
• 59 citations
  Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice.
  Karim R Masri, Timothy S. Shaver, Shadi H. Shahouri, Shirley Wang, James D. Anderson, Ruth E. Busch, Kaleb Michaud, Ted R. Mikuls, Liron Caplan, Frederick Wolfe> ;The Journal of Rheumatology. 2012 Jun 1
• Join now to see all

Journal Articles

• Masri KR and Shaver TS, Rheumatology International, 1/1/2013
• Masri, KR, Moussa R, Licke H, El-Haddad B, Journal of Gastroenterology and Hepatology Research, 1/1/2012
• Masri KR, Shaver TS, Shahouri SH, Wang S, Anderson JD, Busch RE, Michaud K, Mikuls TR, Caplan L, Wolfe F, J Rheumatol, 1/1/2012
• Masri, KR and Salyers, WJ, Kansas Journal of Medicine, 1/1/2012
• Masri, KR and Salyers, WJ, Kansas Journal of Medicine, 1/1/2012
• Masri, KR and Salyers, WJ, Kansas Journal of Medicine, 1/1/2012
• Masri KR, Orozco-Do S, Massey A, Kansas Journal of Medicine, 1/1/2011
• Masri KR, Peters T, Moore J, Kansas Journal of Medicine, 1/1/2011
• Join now to see all

Books/Book Chapters

•  
  Chapter: Office Orthopedics. 
  Page 395 - 404Masri, Karim R., and John A. FlynnEditors: Bimal H. Ashar, Redonda G. Miller, and Stephen D. Sisson.Elsevier, Philadelphia, PAEdition 5th,2016

Other

•  
  Masri, KR, ACR Image Bank
  http://images.rheumatology.org/bp/#/search/detail/14840257
  1/1/2015
•  
  Masri, KR, ACR Image Bank
  http://images.rheumatology.org/bp/#/search/detail/14840277
  1/1/2015
•  
  Masri, KR, ACR Image Bank
  http://images.rheumatology.org/bp/#/search/detail/14840396
  1/1/2015
•  
  Masri, KR, ACR Image Bank
  http://images.rheumatology.org/bp/#/search/detail/14840455
  1/1/2015
•  
  Masri, KR and Kimberley Steele, ACR Image Bank
  http://images.rheumatology.org/bp/#/search/detail/14840476
  1/1/2015
• Join now to see all